We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRV icon
4326
Acrivon Therapeutics
ACRV
$79.2M
$9.93K ﹤0.01%
2,018
+763
+61% +$4.03K
WDTE
4327
Defiance S&P 500 Weekly Distribution ETF
WDTE
$67.4M
$9.92K ﹤0.01%
+183
New +$10.1K
HKIT icon
4328
Hitek Global
HKIT
$27.2M
$9.92K ﹤0.01%
3
+2
+200% +$10.2K
BBGI icon
4329
Beasley Broadcasting Group
BBGI
$44.7M
$9.92K ﹤0.01%
565
-33
-6% -$513
DMTK
4330
DELISTED
DermTech, Inc. Common Stock
DMTK
$9.91K ﹤0.01%
+5,665
New +$8.27K
CADL icon
4331
Candel Therapeutics
CADL
$865M
$9.9K ﹤0.01%
6,733
-1,914
-22% -$1.86K
PIXY
4332
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$9.89K ﹤0.01%
121
+100
+476% +$15.5K
LIVE icon
4333
Live Ventures
LIVE
$30.8M
$9.88K ﹤0.01%
389
-7
-2% -$185
WKHS icon
4334
Workhorse Group
WKHS
$33.1M
$9.86K ﹤0.01%
9
+1
+13% +$1.2K
CDTX
4335
DELISTED
Cidara Therapeutics
CDTX
$9.86K ﹤0.01%
621
+482
+347% +$7.74K
NREF
4336
NexPoint Real Estate Finance
NREF
$318M
$9.86K ﹤0.01%
626
-235
-27% -$3.64K
XGN icon
4337
Exagen
XGN
$159M
$9.85K ﹤0.01%
+4,952
New +$8.56K
FHTX icon
4338
Foghorn Therapeutics
FHTX
$385M
$9.85K ﹤0.01%
1,527
-3,394
-69% -$14.6K
IMA
4339
ImageneBio Inc
IMA
$66.6M
$9.84K ﹤0.01%
416
+107
+35% +$3.49K
KLRS
4340
Kalaris Therapeutics
KLRS
$92.4M
$9.84K ﹤0.01%
629
+351
+126% +$13.8K
SKIL icon
4341
Skillsoft
SKIL
$78.4M
$9.83K ﹤0.01%
559
+84
+18% +$1.47K
BFX
4342
DELISTED
BowFlex Inc.
BFX
$9.81K ﹤0.01%
12,745
+1,946
+18% +$1.32K
BOTZ icon
4343
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
$9.8K ﹤0.01%
344
-117
-25% -$2.99K
PPTA
4344
Perpetua Resources
PPTA
$3.1B
$9.79K ﹤0.01%
3,088
-722
-19% -$2.43K
NXTS
4345
Nexentis Technologies
NXTS
$2.83M
$9.78K ﹤0.01%
20
+12
+150% +$6.93K
BWX icon
4346
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$9.76K ﹤0.01%
421
– –
BIOR
4347
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$9.76K ﹤0.01%
723
+702
+3,343% +$11.4K
SBT
4348
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$9.75K ﹤0.01%
1,690
-7,890
-82% -$45.4K
VIGL
4349
DELISTED
Vigil Neuroscience
VIGL
$9.74K ﹤0.01%
2,883
+532
+23% +$2.74K
RGS icon
4350
Regis Corp
RGS
$70.1M
$9.74K ﹤0.01%
1,031
+805
+356% +$7.68K
172 173
174
175 176

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.